Close
Close
Treatment Database
1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]-2-propen-1-one
Trade Name not avaiable
Orphan Indication Biliary tract cancer
EU Market Approval
EU Designation Date 01-04-2019
Sponsor Taiho Pharma Europe Limited
More about Biliary tract cancer
Free Newsletter
Treatment News
Videos
by Abidemi Uruejoma
59 views
by Abidemi Uruejoma
78 views
by Abidemi Uruejoma
82 views